News

Cantech Letter9m

Health Canada grants marketing authorization for an additional indication of Bayer’s NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate ...

Bayer Inc. is pleased to announce that Health Canada has granted marketing authorization for its oral androgen receptor inhibitor (ARi) NUBEQA® ...
Cantech Letter29m

Government of Canada to match Red Cross donations to Newfoundland and Labrador appeal to help those impacted by wildfires

Today, the Government of Canada announced that it will match every dollar donated to the Canadian Red Cross 2025 Newfoundland & Labrador Wildfires Appeal to ...
Cantech Letter30m

Specsavers Canada highlights 45% of children are not receiving regular eye exams as myopia rate increases

Specsavers emphasizes the importance of early detection through regular eye exams as nearsightedness rates in children continue to grow TORONTO, Aug. 21, 2025 /CNW/ – Myopia ...
Cantech Letter39m

Health Canada Approves Roche’s Columvi® (glofitamab) as the First Bispecific Antibody in Canada for Relapsed or Refractory Diffuse Large B-Cell Lymphoma after Initial Therapy

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that Health Canada has granted market authorization for Columvi® (glofitamab for injection) ...
Cantech Letter1h

Calgary Immigrant Women’s Association wins top place in the Canada Life Literacy Innovation Award

ABC Life Literacy Canada is delighted to announce the recipients of the 2025 Canada Life Literacy Innovation Award (LIA), which recognizes innovative adult ...